Agios' second cancer drug follows the success of its first in early trial
November 19, 2014 at 06:57 AM EST
The second drug in development by Agios Pharmaceuticals lived up to the high expectations set for it, helping eliminate all signs of a blood cancer common in older adults in a third of the patients in a small, early-stage trial...